mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.07 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.07 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.07 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.07 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.07 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
0.07 |